bioMerieux (OTCMKTS:BMXMF) versus Nutex Health (NASDAQ:NUTX) Critical Analysis

by · The Markets Daily

bioMerieux (OTCMKTS:BMXMFGet Free Report) and Nutex Health (NASDAQ:NUTXGet Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, earnings, valuation and dividends.

Insider and Institutional Ownership

5.3% of Nutex Health shares are owned by institutional investors. 36.9% of Nutex Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares bioMerieux and Nutex Health”s top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioMerieux$4.31 billion3.55$467.68 millionN/AN/A
Nutex Health$479.95 million2.47$52.10 million$18.499.07

bioMerieux has higher revenue and earnings than Nutex Health.

Profitability

This table compares bioMerieux and Nutex Health’s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
bioMerieuxN/AN/AN/A
Nutex Health11.62%37.44%14.16%

Analyst Recommendations

This is a summary of current ratings and recommmendations for bioMerieux and Nutex Health, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
bioMerieux01002.00
Nutex Health01202.67

Nutex Health has a consensus target price of $252.50, suggesting a potential upside of 50.62%. Given Nutex Health’s stronger consensus rating and higher possible upside, analysts clearly believe Nutex Health is more favorable than bioMerieux.

Risk and Volatility

bioMerieux has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, Nutex Health has a beta of -0.08, suggesting that its stock price is 108% less volatile than the S&P 500.

Summary

Nutex Health beats bioMerieux on 8 of the 12 factors compared between the two stocks.

About bioMerieux

(Get Free Report)

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

About Nutex Health

(Get Free Report)

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.